Description
The bladder cancer detection kit market was valued at USD 123 Million in 2020, and it is expected to reach 322 million in 2027 with a CAGR of 11.17% during the forecast period 2027. The fast-rising majority of bladder cancer, as well as the ripple in bladder cancer-related death rates, will propel future growth. In addition, the developing essential for non-invasive urothelial cancer diagnosis and the globally aging population will drive up global demand. Fast technological advancements and infrastructural directions withinside the healthcare industry are pushing the growth of the bladder cancer detection kit market. Increased investment by government and healthcare professionals is also anticipated to donate to the market’s global growth in the forthcoming years.
